Prevalence of hot flushes and night sweats around the world: a systematic review

EW Freeman, K Sherif - Climacteric, 2007 - Taylor & Francis
Objective Many studies have evaluated the relationships between ethnicity and culture,
prevalence of menopausal symptoms, and attitudes toward them, but few have assessed …

Symptoms of the menopause

D Bruce, J Rymer - Best practice & research Clinical obstetrics & …, 2009 - Elsevier
Numerous symptoms can be attributed to the lack of oestrogen at the time of the
menopause. Some of the mechanisms for this are still unclear. However, while there is …

Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages

DC Deecher, K Dorries - Archives of women's mental health, 2007 - Springer
Vasomotor symptoms (VMS), commonly called hot flashes or flushes (HFs) and night
sweats, are the menopausal symptoms for which women seek treatment during menopause …

Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: a systematic review and meta-analysis

D Rovinski, RB Ramos, TM Fighera, GK Casanova… - Thrombosis research, 2018 - Elsevier
Introduction Hormone therapy (HT) is an effective treatment for climacteric symptoms.
Nevertheless, combined estrogen-progestin therapy and the oral route seem to entail higher …

Isoflavones—safe food additives or dangerous drugs?

W Wuttke, H Jarry, D Seidlová-Wuttke - Ageing research reviews, 2007 - Elsevier
The sales volume of products containing isoflavone has increased since the publication of
the Women's Health Initiative. The many apparently contradictory results published on the …

Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only …

F Laliberté, K Dea, MS Duh, KH Kahler, M Rolli… - Menopause, 2011 - journals.lww.com
Objective: The aim of this study was to quantify the magnitude of risk reduction for venous
thromboembolism events associated with an estradiol transdermal system relative to oral …

Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment

AJ Rapkin - American journal of obstetrics and gynecology, 2007 - Elsevier
OBJECTIVE: The decline in concentrations of gonadal hormones during menopause gives
rise to a range of physiologic and psychologic changes that may impact a woman's health …

Lowest effective transdermal 17β-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial

GA Bachmann, M Schaefers, A Uddin… - Obstetrics & …, 2007 - journals.lww.com
OBJECTIVE: To investigate the efficacy of micro-dose transdermal estrogen in relieving
menopausal vasomotor symptoms. METHODS: A randomized, double-blind, placebo …

What causes hot flushes? The neuroendocrine origin of vasomotor symptoms in the menopause

WG Rossmanith, W Ruebberdt - Gynecological Endocrinology, 2009 - Taylor & Francis
Vasomotor symptoms (VMS) such as hot flushes and night sweats are frequently
encountered during menopause and can greatly reduce the quality of life. These symptoms …

[HTML][HTML] Comparison of vitex agnus-castus extracts with placebo in reducing menopausal symptoms: a randomized double-blind study

R Naseri, V Farnia, K Yazdchi, M Alikhani… - Korean journal of …, 2019 - ncbi.nlm.nih.gov
Background Menopausal symptoms have remarkable negative effects on women's quality of
life, justifying the need to assess various therapeutic options. This research aimed to …